B. Riley Wealth Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,864
Closed -$76K 1553
2022
Q2
$76K Sell
16,864
-9,102
-35% -$39.5K ﹤0.01% 1149
2022
Q1
$124K Sell
25,966
-605
-2% -$3.35K ﹤0.01% 1273
2021
Q4
$198K Sell
26,571
-1,788
-6% -$11.1K 0.01% 1271
2021
Q3
$170K Hold
28,359
0.01% 1264
2021
Q2
$202K Buy
28,359
+2,932
+12% +$20.5K 0.01% 1213
2021
Q1
$197K Buy
25,427
+2,776
+12% +$22.7K 0.01% 1201
2020
Q4
$147K Sell
22,651
-185
-0.8% -$1.08K 0.01% 955
2020
Q3
$90K Buy
22,836
+697
+3% +$2.81K ﹤0.01% 902
2020
Q2
$102K Sell
22,139
-13,808
-38% -$58.7K 0.01% 816
2020
Q1
$123K Buy
+35,947
New +$157K 0.01% 716
2015
Q1
Sell
-1,014
Closed -$6 2095
2014
Q4
$6 Buy
+1,014
New +$9.27K ﹤0.01% 3110
2014
Q3
Sell
-450
Closed -$5.33K 1982
2014
Q2
$5.33K Buy
+450
New +$5.65K ﹤0.01% 2015

Other funds holding IMGN

B. Riley Wealth Advisors's IMGN Position: Q3 2022 in Review

B. Riley Wealth Advisors sold out of Immunogen Inc (IMGN) in Q3 2022, closing a stake of 16,864 shares — an estimated $76K sold.

B. Riley Wealth Advisors first reported a position in IMGN in Q2 2014 and held it in 12 quarters. The position peaked at $202K in Q2 2021. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.

  • B. Riley Wealth Advisors reported no remaining Immunogen Inc position as of Q3 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 16,864 Immunogen Inc shares in Q3 2022, an estimated $76K.
  • B. Riley Wealth Advisors first reported a position in Immunogen Inc in Q2 2014 and held it in 12 quarters.
  • B. Riley Wealth Advisors's Immunogen Inc position peaked at $202K in Q2 2021.
  • 222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.